Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: Role of the proximal promoter GC-rich region

Neal A. Englert, Robert J. Turesky, Weiguo Han, Erin E. Bessette, Simon D. Spivack, Michele Caggana, David C. Spink, Barbara C. Spink

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, contributes to carcinogenesis through its role in the regulation of cytochrome P450 1 (CYP1)-catalyzed metabolism of carcinogens. Here, we investigated genetic and epigenetic mechanisms that affect AhR expression. Analyses of the human AHR proximal promoter in MCF-7 human breast cancer cells using luciferase assays and electrophoretic mobility shift assays revealed multiple specificity protein (Sp) 1 binding sequences that are transcriptional activators in vitro. The regulation of AhR expression was evaluated in long-term estrogen exposed (LTEE) MCF-7 cells, which showed increased AhR expression, enhanced CYP1 inducibility, and increased capacity to form DNA adducts when exposed to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. The increased AhR expression in LTEE cells was found not to result from increased mRNA stability, differential RNA processing, or decreased DNA methylation. Analysis of the AHR proximal promoter region using chromatin immunoprecipitation confirmed that enhanced expression of AhR in LTEE cells involves changes in histone modifications, notably decreased trimethylation of histone 3, lysine 27. Upon further examination of the GC-rich Sp1-binding region, we confirmed that it contains a polymorphic (GGGGC) n repeat. In a population of newborns from New York State, the allele frequency of (GGGGC) n was n = 4 > 5 6, 2. Circular dichroism spectroscopy revealed the ability of sequences of this GC-rich region to form guanine-quadruplex structures in vitro. These studies revealed multiple levels at which AhR expression may be controlled, and offer additional insights into mechanisms regulating AhR expression that can ultimately impact carcinogenesis.

Original languageEnglish (US)
Pages (from-to)722-735
Number of pages14
JournalBiochemical Pharmacology
Volume84
Issue number5
DOIs
StatePublished - Sep 1 2012

Fingerprint

GC Rich Sequence
Aryl Hydrocarbon Receptors
Gene Expression Regulation
Epigenomics
Gene expression
Cells
Breast Neoplasms
Estrogens
Carcinogens
Histones
Cytochrome P-450 Enzyme System
Assays
Carcinogenesis
Histone Code
G-Quadruplexes
Circular dichroism spectroscopy
Electrophoretic mobility
DNA Adducts
Chromatin Immunoprecipitation
MCF-7 Cells

Keywords

  • (GGGGC) repeat polymorphism
  • 2-Amino-1-methyl-6- phenylimidazo[4,5-b]pyridine
  • Aryl hydrocarbon receptor
  • Epigenetic
  • Guanine-quadruplex
  • Long-term estrogen exposure

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells : Role of the proximal promoter GC-rich region. / Englert, Neal A.; Turesky, Robert J.; Han, Weiguo; Bessette, Erin E.; Spivack, Simon D.; Caggana, Michele; Spink, David C.; Spink, Barbara C.

In: Biochemical Pharmacology, Vol. 84, No. 5, 01.09.2012, p. 722-735.

Research output: Contribution to journalArticle

Englert, Neal A. ; Turesky, Robert J. ; Han, Weiguo ; Bessette, Erin E. ; Spivack, Simon D. ; Caggana, Michele ; Spink, David C. ; Spink, Barbara C. / Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells : Role of the proximal promoter GC-rich region. In: Biochemical Pharmacology. 2012 ; Vol. 84, No. 5. pp. 722-735.
@article{c0647ed44fb04fae897f234b8e09955e,
title = "Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: Role of the proximal promoter GC-rich region",
abstract = "The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, contributes to carcinogenesis through its role in the regulation of cytochrome P450 1 (CYP1)-catalyzed metabolism of carcinogens. Here, we investigated genetic and epigenetic mechanisms that affect AhR expression. Analyses of the human AHR proximal promoter in MCF-7 human breast cancer cells using luciferase assays and electrophoretic mobility shift assays revealed multiple specificity protein (Sp) 1 binding sequences that are transcriptional activators in vitro. The regulation of AhR expression was evaluated in long-term estrogen exposed (LTEE) MCF-7 cells, which showed increased AhR expression, enhanced CYP1 inducibility, and increased capacity to form DNA adducts when exposed to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. The increased AhR expression in LTEE cells was found not to result from increased mRNA stability, differential RNA processing, or decreased DNA methylation. Analysis of the AHR proximal promoter region using chromatin immunoprecipitation confirmed that enhanced expression of AhR in LTEE cells involves changes in histone modifications, notably decreased trimethylation of histone 3, lysine 27. Upon further examination of the GC-rich Sp1-binding region, we confirmed that it contains a polymorphic (GGGGC) n repeat. In a population of newborns from New York State, the allele frequency of (GGGGC) n was n = 4 > 5 6, 2. Circular dichroism spectroscopy revealed the ability of sequences of this GC-rich region to form guanine-quadruplex structures in vitro. These studies revealed multiple levels at which AhR expression may be controlled, and offer additional insights into mechanisms regulating AhR expression that can ultimately impact carcinogenesis.",
keywords = "(GGGGC) repeat polymorphism, 2-Amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, Aryl hydrocarbon receptor, Epigenetic, Guanine-quadruplex, Long-term estrogen exposure",
author = "Englert, {Neal A.} and Turesky, {Robert J.} and Weiguo Han and Bessette, {Erin E.} and Spivack, {Simon D.} and Michele Caggana and Spink, {David C.} and Spink, {Barbara C.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.bcp.2012.06.013",
language = "English (US)",
volume = "84",
pages = "722--735",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells

T2 - Role of the proximal promoter GC-rich region

AU - Englert, Neal A.

AU - Turesky, Robert J.

AU - Han, Weiguo

AU - Bessette, Erin E.

AU - Spivack, Simon D.

AU - Caggana, Michele

AU - Spink, David C.

AU - Spink, Barbara C.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, contributes to carcinogenesis through its role in the regulation of cytochrome P450 1 (CYP1)-catalyzed metabolism of carcinogens. Here, we investigated genetic and epigenetic mechanisms that affect AhR expression. Analyses of the human AHR proximal promoter in MCF-7 human breast cancer cells using luciferase assays and electrophoretic mobility shift assays revealed multiple specificity protein (Sp) 1 binding sequences that are transcriptional activators in vitro. The regulation of AhR expression was evaluated in long-term estrogen exposed (LTEE) MCF-7 cells, which showed increased AhR expression, enhanced CYP1 inducibility, and increased capacity to form DNA adducts when exposed to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. The increased AhR expression in LTEE cells was found not to result from increased mRNA stability, differential RNA processing, or decreased DNA methylation. Analysis of the AHR proximal promoter region using chromatin immunoprecipitation confirmed that enhanced expression of AhR in LTEE cells involves changes in histone modifications, notably decreased trimethylation of histone 3, lysine 27. Upon further examination of the GC-rich Sp1-binding region, we confirmed that it contains a polymorphic (GGGGC) n repeat. In a population of newborns from New York State, the allele frequency of (GGGGC) n was n = 4 > 5 6, 2. Circular dichroism spectroscopy revealed the ability of sequences of this GC-rich region to form guanine-quadruplex structures in vitro. These studies revealed multiple levels at which AhR expression may be controlled, and offer additional insights into mechanisms regulating AhR expression that can ultimately impact carcinogenesis.

AB - The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, contributes to carcinogenesis through its role in the regulation of cytochrome P450 1 (CYP1)-catalyzed metabolism of carcinogens. Here, we investigated genetic and epigenetic mechanisms that affect AhR expression. Analyses of the human AHR proximal promoter in MCF-7 human breast cancer cells using luciferase assays and electrophoretic mobility shift assays revealed multiple specificity protein (Sp) 1 binding sequences that are transcriptional activators in vitro. The regulation of AhR expression was evaluated in long-term estrogen exposed (LTEE) MCF-7 cells, which showed increased AhR expression, enhanced CYP1 inducibility, and increased capacity to form DNA adducts when exposed to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. The increased AhR expression in LTEE cells was found not to result from increased mRNA stability, differential RNA processing, or decreased DNA methylation. Analysis of the AHR proximal promoter region using chromatin immunoprecipitation confirmed that enhanced expression of AhR in LTEE cells involves changes in histone modifications, notably decreased trimethylation of histone 3, lysine 27. Upon further examination of the GC-rich Sp1-binding region, we confirmed that it contains a polymorphic (GGGGC) n repeat. In a population of newborns from New York State, the allele frequency of (GGGGC) n was n = 4 > 5 6, 2. Circular dichroism spectroscopy revealed the ability of sequences of this GC-rich region to form guanine-quadruplex structures in vitro. These studies revealed multiple levels at which AhR expression may be controlled, and offer additional insights into mechanisms regulating AhR expression that can ultimately impact carcinogenesis.

KW - (GGGGC) repeat polymorphism

KW - 2-Amino-1-methyl-6- phenylimidazo[4,5-b]pyridine

KW - Aryl hydrocarbon receptor

KW - Epigenetic

KW - Guanine-quadruplex

KW - Long-term estrogen exposure

UR - http://www.scopus.com/inward/record.url?scp=84864402033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864402033&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2012.06.013

DO - 10.1016/j.bcp.2012.06.013

M3 - Article

C2 - 22728919

AN - SCOPUS:84864402033

VL - 84

SP - 722

EP - 735

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -